Loading...

MERCK Kommanditgesellschaft auf Aktien

MKGAF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$139.41
$5.63(4.21%)
U.S. Market opens in 14h 21m

MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stock Overview

Explore MERCK Kommanditgesellschaft auf Aktien’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap62.7B
P/E Ratio18.93
EPS (TTM)$7.01
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$123.14
3 Months$136.54
1 Year Target$129.97

MKGAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MERCK Kommanditgesellschaft auf Aktien (MKGAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $129.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.93 and a market capitalization of 62.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.21%
5-Day Change
6.93%
1-Month Change
8.42%
3-Month Change
-8.95%
6-Month Change
4.58%
Year-to-Date (YTD) Change
-5.55%
1-Year Change
6.66%
3-Year Change
-21.82%
5-Year Change
-20.68%
All-Time (Max) Change
-78.15%

Contact Information

https://www.merckgroup.com/en
49 6151 72 0
Frankfurter Strasse 250, Darmstadt, NaN, 64293

Company Facts

59,020 Employees
IPO DateAug 3, 2012
CountryDE
Actively Trading

Frequently Asked Questions